Projects

RNDr. Mária Pacalajová, PhD.

International

Current
  • Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
    Program: ERANET
    Duration: 1. 9. 2024 – 31. 8. 2027

National

Current
  • Targeting high-order chromatin regulation for the treatment of poor prognosis uveal melanoma
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • DNA methylation biomarkers as a tool for the implementation of liquid biopsy in uveal melanoma
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Reprogramming pancreatic ductal adenocarcinoma microenvironment towards immunotherapy
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Identification of potential therapeutic targets associated with cisplatin resistance in yolk sac tumors
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Enhancing Drug Testing Reliability Through In Vitro Modeling of the Pancreatic Cancer Tumor Microenvironment
    Program: DoktoGrant
    Duration: 1. 1. 2024 – 31. 12. 2024
  • Combination therapy testing in vivo using an advanced xenograft mouse model mimicking PDAC tumor microenvironment by co-injection of cancer-associated fibroblasts
    Program: DoktoGrant
    Duration: 1. 1. 2023 – 31. 12. 2023
Employees